37
Participants
Start Date
August 31, 2011
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
NBI-98854
12.5 mg powder in bottle once daily for 14 days
NBI-98854
50 mg powder in bottle once daily for 14 days
Placebo
Solution containing no active substance
CAMC Clinical Trials Center, Charleston
Atlanta Center for Medical Research, Atlanta
San Marcus Research Clinic, Inc., Miami
Medical Research Marseilles, Miami
Scientific Clinical Research, Inc., North Miami
St. Louis Clinical Trials, St Louis
Woodland International Research Group, Inc, Little Rock
Clinical Trials of Texas, Inc., San Antonio
Synergy Clinical Research, National City
UCSD Outpatient Psychiatry, San Diego
PCSD - Feighner Research, San Diego
Lead Sponsor
Neurocrine Biosciences
INDUSTRY